The Claim
The FAI Score, a CCTA-derived biomarker of pericoronary inflammation, is elevated in patients with atrial fibrillation after adjustment for traditional risk factors and coronary calcium burden.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with atrial fibrillation have higher levels of a specific imaging biomarker called the FAI Score, which measures inflammation around the heart arteries, even when other known heart risk factors are considered.
See the scientific wording
The FAI Score, a CCTA-derived biomarker of pericoronary inflammation, is elevated in patients with atrial fibrillation even when traditional risk factors and coronary calcium burden are accounted for, suggesting its potential as a novel imaging marker for AF risk stratification.
Inflammation around the heart's main arteries causes fat tissue near those arteries to change, becoming watery and losing fat content. This inflamed fat releases chemicals that spread to the left chamber of the heart, causing scar tissue to form and disrupting the heart's electrical signals, which triggers irregular heartbeats.
What the research says
1 studyPeople with atrial fibrillation had higher levels of inflammation around their heart arteries, measured by a special CT scan tool called FAI Score—even when doctors accounted for their age, weight, and artery blockages. This suggests the tool could help spot who’s at risk for heart rhythm problems.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.